AstraZeneca Pharma India Limited has informed regarding Disclosure of material issue

Regulatory & Legal View source PDF Explain this filing

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹8888.00

prior close

₹8926.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+0.9% vs market

Pharmaceuticals peers, median of 150sector+0.7%+1.2% vs sector

On the reaction day the stock moved 0.9 pts more than Nifty Microcap 250 and 1.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.1

15m

+0.2

30m

+1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9+1.0+0.9+0.7+1.2

Next day

+2.1+0.3+1.8+0.2+1.9

+2.6+0.3+2.3+0.4+2.2

+1.3+0.8+0.5+0.5+0.8

+2.1+0.9+1.2+0.6+1.5

+1.3+1.4-0.1+0.6+0.6

+1.4+1.2+0.2+0.8+0.6

15d

-0.9+1.8-2.7+1.0-1.9

+5.1+0.1+5.0-1.2+6.3

+10.1+2.4+7.8-1.2+11.3

+2.3-2.8+5.1-5.7+7.9

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

AstraZeneca Pharma India Limited has submitted a disclosure to the stock exchanges regarding a material issue. The full nature and details of the issue have not been disclosed in the headline itself. Investors would need to refer to the company's detailed filing or communication to understand what the material matter pertains to and how it may affect the business or operations.

Likely market impact

Without further details on the nature of the material issue, the immediate impact on shareholders or the stock price remains uncertain. Investors should monitor the company's detailed disclosure and any follow-up filings to assess whether the matter is positive, neutral, or negative for the business.